• McAlpine's Multiple Sclerosis See large image

    McAlpine's Multiple Sclerosis (Hardback) By (author) Alastair Compston, By (author) Ian R. McDonald, By (author) John Noseworthy, By (author) Hans Lassmann, By (author) David H. Miller, By (author) Kenneth J. Smith, By (author) Hartmut Wekerle, By (author) Christian Confavreux

    $212.68 - Save $76.00 26% off - RRP $288.68 Free delivery worldwide Available
    Dispatched in 1 business day
    When will my order arrive?
    Add to basket | Add to wishlist |

    DescriptionSince 1955, this landmark masterwork has been revered for its authoritative presentation of the entire state of scientific and clinical knowledge about multiple sclerosis. This new edition summarises the state of knowledge on this common neurological disease to mid-2005. No person who aspires to know about multiple sclerosis can do without this book! The state-of-the-art 4th Edition presents the most recent information on the genetics and epidemiology, clinical neurology, pathogenesis, and management of this common neurological disease. Amply illustrated and referenced and beautifully written, "McAlpine's Multiple Sclerosis" has been described as - 'A standard reference for multiple sclerosis researchers, embryonic 'MS-ologists' and hard-pressed clinical neurologists alike' - ("Brain", review of the last edition).


Other books

Other books in this category
Showing items 1 to 11 of 11

 

Reviews | Bibliographic data
  • Full bibliographic data for McAlpine's Multiple Sclerosis

    Title
    McAlpine's Multiple Sclerosis
    Authors and contributors
    By (author) Alastair Compston, By (author) Ian R. McDonald, By (author) John Noseworthy, By (author) Hans Lassmann, By (author) David H. Miller, By (author) Kenneth J. Smith, By (author) Hartmut Wekerle, By (author) Christian Confavreux
    Physical properties
    Format: Hardback
    Number of pages: 992
    Width: 226 mm
    Height: 279 mm
    Thickness: 51 mm
    Weight: 3,175 g
    Language
    English
    ISBN
    ISBN 13: 9780443072710
    ISBN 10: 044307271X
    Classifications

    Warengruppen-Systematik des deutschen Buchhandels: 16960
    BIC E4L: HEA
    B&T Book Type: NF
    Nielsen BookScan Product Class 3: S6.2
    Ingram Subject Code: PI
    B&T Modifier: Region of Publication: 03
    BIC subject category V2: MJN
    B&T Modifier: Text Format: 41
    B&T General Subject: 510
    DC22: 616.834
    BIC subject category V2: MBPC
    B&T Modifier: Academic Level: 02
    B&T Merchandise Category: MAJ
    BISAC V2.8: MED056000, MED083000
    DC22: 616.8/34
    LC subject heading:
    B&T Approval Code: N67304400
    Libri: MULT4500
    LC classification: RC377 .M43 2005
    Thema V1.0: MKJ
    Edition
    4, Revised
    Edition statement
    4th Revised edition
    Illustrations note
    570 ills.
    Publisher
    Elsevier Health Sciences
    Imprint name
    CHURCHILL LIVINGSTONE
    Publication date
    15 December 2005
    Publication City/Country
    London
    Review quote
    REVIEWS OF THE LAST EDITION: "The principal merit of this book is the clear and coherent approach of the six authors, who are the world's leading figures in the field, to describing and interpreting the many complex and variable aspects of multiple sclerosis."-NEJM" Since its inception, McAlpine's Multiple Sclerosis has achieved the rare distinction of becoming one of the classical neurological texts of the last century. The possession of this book was a priority for anyone practising neurology and a necessary acquisition for any self-respecting medical library."-Brain"The authors must be warmly congratulated on producing an outstanding reference text that Nigel Compston and his original coauthors would be immensely proud of, their intention at the outset being that of simulating interest 'in the ever widening field of demyelinating disease'. This book clearly fulfils that legacy and definitively presents the current state of knowledge."- J Neurol Neurosurg Psychiatry
    Table of contents
    SECTION ONE: THE STORY OF MULTIPLE SCLEROSIS 1. The story of multiple sclerosis The evolving concept of multiple sclerosis Naming and classifying the disease: 1868-1983 Clinical descriptions of multiple sclerosis: 1838-1981 Personal accounts of multiple sclerosis: 1824-1991 The social history of multiple sclerosis: 1945-1998 The pathogenesis and clinical anatomy of multiple sclerosis: 1849-1977 The laboratory science of multiple sclerosis: 1912-1981 Discovery of glia and remyelination: 1858-1988 The aetiology of multiple sclerosis: 1883-1976 Attitudes to the treatment of multiple sclerosis: 1841-1983 SECTION TWO: THE CAUSE AND COURSE OF MULTIPLE SCLEROSIS 2. The distribution of multiple sclerosis The rationale for epidemiological studies in multiple sclerosis Definitions and statistics in epidemiology Strategies for epidemiological studies in multiple sclerosis The geography of multiple sclerosis Epidemics and clusters of multiple sclerosis The environmental factor in multiple sclerosis 3. The genetics of multiple sclerosis: Genetic analysis of multiple sclerosis Methods of genetic analysis Racial susceptibility Sex differences in susceptibility Familial multiple sclerosis Candidate genes in multiple sclerosis Systematic genome screening Lessons from genetic studies of experimental allergic encephalomyelitis Conclusions 4. The natural history of multiple sclerosis Introduction Definitions Onset Course Inter-individual variability Factors affecting the prognosis General considerations Environmental influences Chapter 5: The aetiology of multiple sclerosis: an epitome SECTION THREE: THE CLINICAL FEATURES AND DIAGNOSIS OF MULTIPLE SCLEROSIS 6. The symptoms and signs of multiple sclerosis. Multiple sclerosis as a neurological illness Initial symptoms Symptoms and signs in the course of the disease Individual symptoms and sign Associated diseases Conclusion 7. The diagnosis of multiple sclerosis Diagnostic criteria for multiple sclerosis Selection of investigations Magnetic resonance imaging Evoked potentials Examination of the cerebrospinal fluid A strategy for the investigation of demyelinating disease 8. The differential diagnosis of multiple sclerosis The spectrum of disorders mimicking multiple sclerosis Diseases that may cause multiple lesions of the CNS and also often follow a relapsing remitting course Systematized central nervous system diseases Isolated or monosymptomatic CNS syndromes Non organic symptoms How accurate is the diagnosis of multiple sclerosis? 9. Multiple sclerosis in the individual and in groups: a conspectus The typical case Isolated syndromes and their outcome: judicious use of investigations and critique of the new diagnostic criteria Co-morbidity and associated diseases Situations in which alternative diagnoses should be considered When to ignore "inconvenient" laboratory results or clinical findings: taking the best position "Pathognomonic" and "un-heard of" features of multiple sclerosis SECTION FOUR: THE PATHOGENESIS OF MULTIPLE SCLEROSIS 10. The neurobiology of multiple sclerosis. Organisation in the central nervous system Development of the central nervous system Macroglial lineages in the rodent and human nervous system Axon-glial interactions and myelination Demyelination Axon degeneration and restoration of function Remyelination 11. The immunology of inflammatory demyelinating disease Multiple sclerosis as an autoimmune disease Immune responses: innate and adaptive T lymphocytes B lymphocytes Autoimmunity and self tolerance in the central nervous system Regulation of central nervous system autoimmune responses Immune reactivity in the central nervous system Pathogenesis of demyelination and tissue damage Peripheral blood biomarkers for multiple sclerosis and disease activity Markers of multiple sclerosis and disease activity in cerebrospinal fluid Conclusion 12. The pathology of multiple sclerosis Introduction Pathological classification of demyelinating diseases The demyelinated plaque Immunopathology of inflammation Demyelination and oligodendroglial damge Remyelination Axonal pathology Grey matter pathology / cortical plaques Astroglia reaction Abnormalities in the "normal" white matter Distribution of lesions in the nervous system Is there evidence for an infectious agent in the lesions of multiple sclerosis? Dynamic evolution of multiple sclerosis pathology Differences between acute relapsing and progressive multiple sclerosis Molecular approaches to the study of the MS lesion: Global profiling of transcriptome and proteome. Association of multiple sclerosis with other diseases Conclusions 13. The pathophysiology of multiple sclerosis Introduction Methods for exploring the pathophysiology of multiple sclerosis Relapsing remitting multiple sclerosis: loss of function due to conduction block Relapsing remitting multiple sclerosis: recovery of function and remission Physiological explanations for other clinical symptoms in multiple sclerosis Permanent loss of function in the context of disease progression Summary SECTION FIVE: THE TREATMENT OF MULTIPLE SCLEROSIS 15. Care of the person with multiple sclerosis General approach to the care of people with multiple sclerosis The early stages of disease: minimal disability The middle stages of disease: moderate disability The later stages of disease: severe disability Guidelines for the management and investigation of multiple sclerosis Conclusion 16. Treatment of the acute relapse The features of active multiple sclerosis The treatment of relapse in multiple sclerosis Other approaches to the treatment of acute relapse Treatment of acute optic neuritis Management of other central nervous system demyelinating disorders Adverse effects of corticosteroids Mode of action of corticosteroids Practice Guidelines 17. The treatment of symptoms in multiple sclerosis and the role of rehabilitation The general principles of symptomatic treatment in multiple sclerosis Disturbances of autonomic function Mobility and gait disturbance Fatigue Disturbances of brain stem function Perturbations of nerve conduction Cognition Visual symptoms Rehabilitation in multiple sclerosis Summary 18. Disease modifying treatments in multiple sclerosis The aims of disease modifying treatment The principles of evidence based prescribing in multiple sclerosis The role of magnetic resonance imaging in clinical trials Drugs that stimulate the immune response Drugs that non-specifically suppress the immune response The beta interferons Molecules that inhibit T cell-peptide binding Specific treatments that target T cells Agents which inhibit macrophages and their mediators Recent miscellaneous treatments Postscript 19: The person with multiple sclerosis: present and future Empirical versus hypothesis driven therapeutics New opportunities for immunological intervention Axon protection; acute and chronic Treatment in special situations Remyelination: Index